3TOC: Cerebral and Cognitive Markers of Treatment Resistance in Obsessive Compulsive Disorder

Sponsor
Centre Hospitalier Henri Laborit (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05843604
Collaborator
(none)
100
28.1

Study Details

Study Description

Brief Summary

This study aims to define individual profiles of treatment resistants in order to find indicators and predictors of the therapeutic response.

Condition or Disease Intervention/Treatment Phase
  • Other: Functional MRI

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Cerebral and Cognitive Markers of Treatment Resistance in Obsessive-compulsive Disorder: Towards Personalization of Patient Care
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
May 1, 2025
Anticipated Study Completion Date :
Sep 1, 2025

Arms and Interventions

Arm Intervention/Treatment
obsessive compulsive disorder patients

Other: Functional MRI
Three cognitive tests will be performed in the MRI, namely a stroop task, an N-back task and a switching task

Control Patients

Other: Functional MRI
Three cognitive tests will be performed in the MRI, namely a stroop task, an N-back task and a switching task

Outcome Measures

Primary Outcome Measures

  1. Cerebral activity modification during N-back task [Day 1]

    Blood-oxygen-level-dependent (BOLD) modification during the task between obsessive compulsive disorder patients and controls

  2. Cerebral activity modification during Stroop task [Day 1]

    Blood-oxygen-level-dependent (BOLD) modification during the task between obsessive compulsive disorder patients and controls

  3. Cerebral activity modification during switching task (Monsell et Mizon task ) [Day 1]

    Blood-oxygen-level-dependent (BOLD) modification during the task between obsessive compulsive disorder patients and controls

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Obsessive compulsive disorder diagnosed according to Diagnostic and Statistical Manual 5 criteria (patients will be included regardless of the severity and resistance of their pathology and their levels of executive functions)

  • Understand and accept the constraints of the study

  • Be a beneficiary or affiliated to a Health Insurance scheme

Exclusion Criteria:
  • Present one of the diagnoses according to the criteria of the DSM 5: schizophrenic disorders, substance abuse or dependence to a substance according to the criteria of the M.I.N.I. version 5.0 (Sheehan et al., 1998)

  • Generalized anxiety disorder, social anxiety, nicotine dependence and history of a major depressive episode are not exclusion criteria according to the M.I.N.I. version 5.0 (Sheehan et al., 1998)

  • Have a serious intercurrent pathology

  • Being a pregnant woman

  • Being a woman of childbearing age without effective contraception.

  • Being hospitalized under duress or on an outpatient basis in a care program

  • Being under judicial protection (reinforced curatorship, guardianship)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Centre Hospitalier Henri Laborit

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Henri Laborit
ClinicalTrials.gov Identifier:
NCT05843604
Other Study ID Numbers:
  • 2022-A00463-40
First Posted:
May 6, 2023
Last Update Posted:
May 6, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Henri Laborit
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2023